 | • レポートコード：MRC2-11QY12205 • 出版社/出版日：QYResearch / 2020年11月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIV-AIDS検査のグローバル市場について調査・分析したレポートです。種類別（キット・試薬、器具、その他）市場規模、用途別（病院、私立診断研究所、学術・研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIV-AIDS検査の競争状況、市場シェア ・世界のHIV-AIDS検査市場：種類別市場規模 2015年-2020年（キット・試薬、器具、その他） ・世界のHIV-AIDS検査市場：種類別市場規模予測 2021年-2026年（キット・試薬、器具、その他） ・世界のHIV-AIDS検査市場：用途別市場規模 2015年-2020年（病院、私立診断研究所、学術・研究機関、その他） ・世界のHIV-AIDS検査市場：用途別市場規模予測 2021年-2026年（病院、私立診断研究所、学術・研究機関、その他） ・北米のHIV-AIDS検査市場分析：米国、カナダ ・ヨーロッパのHIV-AIDS検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIV-AIDS検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIV-AIDS検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIV-AIDS検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Affymetrix、Beckman Coulter/Danaher、Becton Dickinson、bioMerieux、Bio-Rad、Cepheid、Diamedix、DiaSorin、Eiken Chemical、Elitech Group、Enzo Biochem、Fujirebio、Lonza、Roche、Scienion、Sequenom、SeraCare、Siemens、Takara Bio ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.
HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.
Market Analysis and Insights: Global HIV-AIDS Testing Market
The global HIV-AIDS Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HIV-AIDS Testing Scope and Market Size
HIV-AIDS Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV-AIDS Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Lonza
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Market segment by Type, the product can be split into
Kits and Reagents
Instruments
Others
Market segment by Application, split into
Hospitals
Private Diagnostics Laboratories
Academic and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV-AIDS Testing Revenue
1.4 Market by Type
1.4.1 Global HIV-AIDS Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits and Reagents
1.4.3 Instruments
1.4.4 Others
1.5 Market by Application
1.5.1 Global HIV-AIDS Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Private Diagnostics Laboratories
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global HIV-AIDS Testing Market Perspective (2015-2026)
2.2 Global HIV-AIDS Testing Growth Trends by Regions
2.2.1 HIV-AIDS Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV-AIDS Testing Historic Market Share by Regions (2015-2020)
2.2.3 HIV-AIDS Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV-AIDS Testing Market Growth Strategy
2.3.6 Primary Interviews with Key HIV-AIDS Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top HIV-AIDS Testing Players by Market Size
3.1.1 Global Top HIV-AIDS Testing Players by Revenue (2015-2020)
3.1.2 Global HIV-AIDS Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV-AIDS Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV-AIDS Testing Market Concentration Ratio
3.2.1 Global HIV-AIDS Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV-AIDS Testing Revenue in 2019
3.3 HIV-AIDS Testing Key Players Head office and Area Served
3.4 Key Players HIV-AIDS Testing Product Solution and Service
3.5 Date of Enter into HIV-AIDS Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV-AIDS Testing Historic Market Size by Type (2015-2020)
4.2 Global HIV-AIDS Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global HIV-AIDS Testing Market Size by Application (2015-2020)
5.2 Global HIV-AIDS Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HIV-AIDS Testing Market Size (2015-2020)
6.2 HIV-AIDS Testing Key Players in North America (2019-2020)
6.3 North America HIV-AIDS Testing Market Size by Type (2015-2020)
6.4 North America HIV-AIDS Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe HIV-AIDS Testing Market Size (2015-2020)
7.2 HIV-AIDS Testing Key Players in Europe (2019-2020)
7.3 Europe HIV-AIDS Testing Market Size by Type (2015-2020)
7.4 Europe HIV-AIDS Testing Market Size by Application (2015-2020)
8 China
8.1 China HIV-AIDS Testing Market Size (2015-2020)
8.2 HIV-AIDS Testing Key Players in China (2019-2020)
8.3 China HIV-AIDS Testing Market Size by Type (2015-2020)
8.4 China HIV-AIDS Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan HIV-AIDS Testing Market Size (2015-2020)
9.2 HIV-AIDS Testing Key Players in Japan (2019-2020)
9.3 Japan HIV-AIDS Testing Market Size by Type (2015-2020)
9.4 Japan HIV-AIDS Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia HIV-AIDS Testing Market Size (2015-2020)
10.2 HIV-AIDS Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV-AIDS Testing Market Size by Type (2015-2020)
10.4 Southeast Asia HIV-AIDS Testing Market Size by Application (2015-2020)
11 India
11.1 India HIV-AIDS Testing Market Size (2015-2020)
11.2 HIV-AIDS Testing Key Players in India (2019-2020)
11.3 India HIV-AIDS Testing Market Size by Type (2015-2020)
11.4 India HIV-AIDS Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America HIV-AIDS Testing Market Size (2015-2020)
12.2 HIV-AIDS Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV-AIDS Testing Market Size by Type (2015-2020)
12.4 Central & South America HIV-AIDS Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott HIV-AIDS Testing Introduction
13.1.4 Abbott Revenue in HIV-AIDS Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Affymetrix
13.2.1 Affymetrix Company Details
13.2.2 Affymetrix Business Overview
13.2.3 Affymetrix HIV-AIDS Testing Introduction
13.2.4 Affymetrix Revenue in HIV-AIDS Testing Business (2015-2020)
13.2.5 Affymetrix Recent Development
13.3 Beckman Coulter/Danaher
13.3.1 Beckman Coulter/Danaher Company Details
13.3.2 Beckman Coulter/Danaher Business Overview
13.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Introduction
13.3.4 Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2015-2020)
13.3.5 Beckman Coulter/Danaher Recent Development
13.4 Becton Dickinson
13.4.1 Becton Dickinson Company Details
13.4.2 Becton Dickinson Business Overview
13.4.3 Becton Dickinson HIV-AIDS Testing Introduction
13.4.4 Becton Dickinson Revenue in HIV-AIDS Testing Business (2015-2020)
13.4.5 Becton Dickinson Recent Development
13.5 bioMerieux
13.5.1 bioMerieux Company Details
13.5.2 bioMerieux Business Overview
13.5.3 bioMerieux HIV-AIDS Testing Introduction
13.5.4 bioMerieux Revenue in HIV-AIDS Testing Business (2015-2020)
13.5.5 bioMerieux Recent Development
13.6 Bio-Rad
13.6.1 Bio-Rad Company Details
13.6.2 Bio-Rad Business Overview
13.6.3 Bio-Rad HIV-AIDS Testing Introduction
13.6.4 Bio-Rad Revenue in HIV-AIDS Testing Business (2015-2020)
13.6.5 Bio-Rad Recent Development
13.7 Cepheid
13.7.1 Cepheid Company Details
13.7.2 Cepheid Business Overview
13.7.3 Cepheid HIV-AIDS Testing Introduction
13.7.4 Cepheid Revenue in HIV-AIDS Testing Business (2015-2020)
13.7.5 Cepheid Recent Development
13.8 Diamedix
13.8.1 Diamedix Company Details
13.8.2 Diamedix Business Overview
13.8.3 Diamedix HIV-AIDS Testing Introduction
13.8.4 Diamedix Revenue in HIV-AIDS Testing Business (2015-2020)
13.8.5 Diamedix Recent Development
13.9 DiaSorin
13.9.1 DiaSorin Company Details
13.9.2 DiaSorin Business Overview
13.9.3 DiaSorin HIV-AIDS Testing Introduction
13.9.4 DiaSorin Revenue in HIV-AIDS Testing Business (2015-2020)
13.9.5 DiaSorin Recent Development
13.10 Eiken Chemical
13.10.1 Eiken Chemical Company Details
13.10.2 Eiken Chemical Business Overview
13.10.3 Eiken Chemical HIV-AIDS Testing Introduction
13.10.4 Eiken Chemical Revenue in HIV-AIDS Testing Business (2015-2020)
13.10.5 Eiken Chemical Recent Development
13.11 Elitech Group
10.11.1 Elitech Group Company Details
10.11.2 Elitech Group Business Overview
10.11.3 Elitech Group HIV-AIDS Testing Introduction
10.11.4 Elitech Group Revenue in HIV-AIDS Testing Business (2015-2020)
10.11.5 Elitech Group Recent Development
13.12 Enzo Biochem
10.12.1 Enzo Biochem Company Details
10.12.2 Enzo Biochem Business Overview
10.12.3 Enzo Biochem HIV-AIDS Testing Introduction
10.12.4 Enzo Biochem Revenue in HIV-AIDS Testing Business (2015-2020)
10.12.5 Enzo Biochem Recent Development
13.13 Fujirebio
10.13.1 Fujirebio Company Details
10.13.2 Fujirebio Business Overview
10.13.3 Fujirebio HIV-AIDS Testing Introduction
10.13.4 Fujirebio Revenue in HIV-AIDS Testing Business (2015-2020)
10.13.5 Fujirebio Recent Development
13.14 Lonza
10.14.1 Lonza Company Details
10.14.2 Lonza Business Overview
10.14.3 Lonza HIV-AIDS Testing Introduction
10.14.4 Lonza Revenue in HIV-AIDS Testing Business (2015-2020)
10.14.5 Lonza Recent Development
13.15 Roche
10.15.1 Roche Company Details
10.15.2 Roche Business Overview
10.15.3 Roche HIV-AIDS Testing Introduction
10.15.4 Roche Revenue in HIV-AIDS Testing Business (2015-2020)
10.15.5 Roche Recent Development
13.16 Scienion
10.16.1 Scienion Company Details
10.16.2 Scienion Business Overview
10.16.3 Scienion HIV-AIDS Testing Introduction
10.16.4 Scienion Revenue in HIV-AIDS Testing Business (2015-2020)
10.16.5 Scienion Recent Development
13.17 Sequenom
10.17.1 Sequenom Company Details
10.17.2 Sequenom Business Overview
10.17.3 Sequenom HIV-AIDS Testing Introduction
10.17.4 Sequenom Revenue in HIV-AIDS Testing Business (2015-2020)
10.17.5 Sequenom Recent Development
13.18 SeraCare
10.18.1 SeraCare Company Details
10.18.2 SeraCare Business Overview
10.18.3 SeraCare HIV-AIDS Testing Introduction
10.18.4 SeraCare Revenue in HIV-AIDS Testing Business (2015-2020)
10.18.5 SeraCare Recent Development
13.19 Siemens
10.19.1 Siemens Company Details
10.19.2 Siemens Business Overview
10.19.3 Siemens HIV-AIDS Testing Introduction
10.19.4 Siemens Revenue in HIV-AIDS Testing Business (2015-2020)
10.19.5 Siemens Recent Development
13.20 Takara Bio
10.20.1 Takara Bio Company Details
10.20.2 Takara Bio Business Overview
10.20.3 Takara Bio HIV-AIDS Testing Introduction
10.20.4 Takara Bio Revenue in HIV-AIDS Testing Business (2015-2020)
10.20.5 Takara Bio Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. HIV-AIDS Testing Key Market Segments
Table 2. Key Players Covered: Ranking by HIV-AIDS Testing Revenue
Table 3. Ranking of Global Top HIV-AIDS Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV-AIDS Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kits and Reagents
Table 6. Key Players of Instruments
Table 7. Key Players of Others
Table 8. Global HIV-AIDS Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global HIV-AIDS Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global HIV-AIDS Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global HIV-AIDS Testing Market Share by Regions (2015-2020)
Table 12. Global HIV-AIDS Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global HIV-AIDS Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. HIV-AIDS Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key HIV-AIDS Testing Players
Table 19. Global HIV-AIDS Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global HIV-AIDS Testing Market Share by Players (2015-2020)
Table 21. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV-AIDS Testing as of 2019)
Table 22. Global HIV-AIDS Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV-AIDS Testing Product Solution and Service
Table 25. Date of Enter into HIV-AIDS Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global HIV-AIDS Testing Market Size Share by Type (2015-2020)
Table 29. Global HIV-AIDS Testing Revenue Market Share by Type (2021-2026)
Table 30. Global HIV-AIDS Testing Market Size Share by Application (2015-2020)
Table 31. Global HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global HIV-AIDS Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 35. North America HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America HIV-AIDS Testing Market Share by Type (2015-2020)
Table 37. North America HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America HIV-AIDS Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 41. Europe HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe HIV-AIDS Testing Market Share by Type (2015-2020)
Table 43. Europe HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe HIV-AIDS Testing Market Share by Application (2015-2020)
Table 45. China Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 47. China HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China HIV-AIDS Testing Market Share by Type (2015-2020)
Table 49. China HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China HIV-AIDS Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 53. Japan HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan HIV-AIDS Testing Market Share by Type (2015-2020)
Table 55. Japan HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan HIV-AIDS Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 59. Southeast Asia HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia HIV-AIDS Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia HIV-AIDS Testing Market Share by Application (2015-2020)
Table 63. India Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 65. India HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India HIV-AIDS Testing Market Share by Type (2015-2020)
Table 67. India HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India HIV-AIDS Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players HIV-AIDS Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players HIV-AIDS Testing Market Share (2019-2020)
Table 71. Central & South America HIV-AIDS Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America HIV-AIDS Testing Market Share by Type (2015-2020)
Table 73. Central & South America HIV-AIDS Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America HIV-AIDS Testing Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Affymetrix Company Details
Table 81. Affymetrix Business Overview
Table 82. Affymetrix Product
Table 83. Affymetrix Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 84. Affymetrix Recent Development
Table 85. Beckman Coulter/Danaher Company Details
Table 86. Beckman Coulter/Danaher Business Overview
Table 87. Beckman Coulter/Danaher Product
Table 88. Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 89. Beckman Coulter/Danaher Recent Development
Table 90. Becton Dickinson Company Details
Table 91. Becton Dickinson Business Overview
Table 92. Becton Dickinson Product
Table 93. Becton Dickinson Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 94. Becton Dickinson Recent Development
Table 95. bioMerieux Company Details
Table 96. bioMerieux Business Overview
Table 97. bioMerieux Product
Table 98. bioMerieux Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 99. bioMerieux Recent Development
Table 100. Bio-Rad Company Details
Table 101. Bio-Rad Business Overview
Table 102. Bio-Rad Product
Table 103. Bio-Rad Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 104. Bio-Rad Recent Development
Table 105. Cepheid Company Details
Table 106. Cepheid Business Overview
Table 107. Cepheid Product
Table 108. Cepheid Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 109. Cepheid Recent Development
Table 110. Diamedix Business Overview
Table 111. Diamedix Product
Table 112. Diamedix Company Details
Table 113. Diamedix Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 114. Diamedix Recent Development
Table 115. DiaSorin Company Details
Table 116. DiaSorin Business Overview
Table 117. DiaSorin Product
Table 118. DiaSorin Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 119. DiaSorin Recent Development
Table 120. Eiken Chemical Company Details
Table 121. Eiken Chemical Business Overview
Table 122. Eiken Chemical Product
Table 123. Eiken Chemical Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 124. Eiken Chemical Recent Development
Table 125. Elitech Group Company Details
Table 126. Elitech Group Business Overview
Table 127. Elitech Group Product
Table 128. Elitech Group Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 129. Elitech Group Recent Development
Table 130. Enzo Biochem Company Details
Table 131. Enzo Biochem Business Overview
Table 132. Enzo Biochem Product
Table 133. Enzo Biochem Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 134. Enzo Biochem Recent Development
Table 135. Fujirebio Company Details
Table 136. Fujirebio Business Overview
Table 137. Fujirebio Product
Table 138. Fujirebio Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 139. Fujirebio Recent Development
Table 140. Lonza Company Details
Table 141. Lonza Business Overview
Table 142. Lonza Product
Table 143. Lonza Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 144. Lonza Recent Development
Table 145. Roche Company Details
Table 146. Roche Business Overview
Table 147. Roche Product
Table 148. Roche Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 149. Roche Recent Development
Table 150. Scienion Company Details
Table 151. Scienion Business Overview
Table 152. Scienion Product
Table 153. Scienion Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 154. Scienion Recent Development
Table 155. Sequenom Company Details
Table 156. Sequenom Business Overview
Table 157. Sequenom Product
Table 158. Sequenom Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 159. Sequenom Recent Development
Table 160. SeraCare Company Details
Table 161. SeraCare Business Overview
Table 162. SeraCare Product
Table 163. SeraCare Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 164. SeraCare Recent Development
Table 165. Siemens Company Details
Table 166. Siemens Business Overview
Table 167. Siemens Product
Table 168. Siemens Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 169. Siemens Recent Development
Table 170. Takara Bio Company Details
Table 171. Takara Bio Business Overview
Table 172. Takara Bio Product
Table 173. Takara Bio Revenue in HIV-AIDS Testing Business (2015-2020) (Million US$)
Table 174. Takara Bio Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV-AIDS Testing Market Share by Type: 2020 VS 2026
Figure 2. Kits and Reagents Features
Figure 3. Instruments Features
Figure 4. Others Features
Figure 5. Global HIV-AIDS Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Private Diagnostics Laboratories Case Studies
Figure 8. Academic and Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. HIV-AIDS Testing Report Years Considered
Figure 11. Global HIV-AIDS Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global HIV-AIDS Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global HIV-AIDS Testing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global HIV-AIDS Testing Market Share by Players in 2019
Figure 16. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV-AIDS Testing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by HIV-AIDS Testing Revenue in 2019
Figure 18. North America HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America HIV-AIDS Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
HIV/AIDS診断の世界市場（～2026年） Market Analysis and Insights: Global HIV/AIDS Diagnostics Market The global HIV/AIDS Diagnostics market size is projected to reach US$ 2808.6 million by 2026, from US$ 2661.7 million in 2020, at a CAGR of 5.1%% during 2021-2026. Global HIV/AIDS Diagnostics Scope and Market Size HIV/AIDS Diagnostics …- 診療所用診断検査の世界市場（～2026年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…
- 病院用微生物検査の世界市場（～2026年） Hospital microbiology testing is a part of clinical laboratory testing involved in conducting multiple tests and blood collections in hospitals. It enables adequate management of threats of infectious diseases. Global hospital microbiology testing market is expected to witness lucrative growth over …
- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 分散型/ POC凝固検査の世界市場（～2026年） Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result…